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Abstract 
In a previous study we found that HTLV-I encoded Tax tramactivator, which binds to NF-xB1 ~105, suppresses pl05-mediated IxB activity, 
thereby allowing entry of NF-XB p65 (RelA) and ~50 into the nucleus. In the present report, we compared the effect of Tax on NF-lcB2 ~100, which 
also binds to Tax, with that of p105 in transfected COS7 cells. While ~105 is processed to the DNA binding form, ~50, processing of plO0 was much 
less efficient both in the presence and absence of Tax. Both ~10.5 and ~100 showed IKB activity in sequestering NF-)cB p65 into the cytoplasm. 
However, only pl05-mediated IlcB activity, and not that of ~100, was inhibited by Tax. Chimer& molecules between ~100 and ~105 suggested that 
inefficient processing of plO0 can be attributed to the Rel homologous domain, rather than to the ankyrin repeat domain. ~100, but not ~105, potently 
suppressed Tax- and p65-induced transactivation of a GM-CSF promoter in Jurkat cells. Taken together, these results suggest hat ~105 and ~100 
may have distinct effects on Tax-induced rransactivation events. 
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NF-rcI3 transcription factor which consists of a heter- 
odimer of two subunits, NF-KB ~65 and ~50 [1,2] is 
sequestered into the cytoplasm through an interaction 
with the inhibitor factor, IrcB. Various stimuli, includ- 
ing phorbol ester of TNF-a treatment, lead to the disso- 
ciation of ~6%~50 from IKB, then translocation into the 
nucleus and activation of NF-KB-responsive genes. 
Human T-cell leukemia virus type-1 (HTLV-Q-encoded 
Tax protein also induces NF-KB in the nucleus [3-51. 
Molecular cloning of cDNA encoding NF-rcB ~50 indi- 
cated that p50 is derived from a 105 kDa precursor, 
NF-xBI ~105, which has a Rel homolo~ domain 
(RHD) and an ankyrin repeat domain (ARD) in the 
amino- and carboxy-terminal portions, respectively [6]. 
The precursor ~105 itself possesses an IrcB function re- 
taining ~50, ~65 and c-Rel in the cytoplasm [7-91. We 
recently reported that Tax relieves pl05-mediated IKB 
activity and induces p50 and ~65 in the nucleus 171. This 
mechanism may, to some extent, account for the induc- 
tion of NF-KB by Tax. 
NF-KBZ p 100, previously referred to as plOOip49, 
p5OB or LytlO, which is homologous to NF-KBI ~105, 
has been described [lO-121. ~100 also contains a RHD 
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and an ART), retains IKB-function 1131 and binds to Tax 
[14]. These lines of evidence prompted us to compare the 
properties of ~100 and ~105 with regard to the Tax 
response. 
2. Materials and methods 
2.1. Ceils and transfect~on 
COS7 cells and Jurkat cells were maintained in DMEM and 
RPM11640 medium, respectively, supplemented with 10% fetal bovine 
serum, penicillin (100 U/ml) and streptomycin (100 mg/ml). Transfec- 
tion was done using a DEAE-dextran method with chloroquine treat- 
ment [15]. The total amounts of the DNA transfected were adjusted by 
adding pMEl8S vector. 
2.2. Plasmid co~t~ction 
Construction ofpME18Sp65, pcDSRa-~105, pcDSRa-plO5dX and 
pcDSRa-Tax has been described elsewhere [7]. The cDNA of NF-xB2 
~100 [11] was subcloned into the pME18S vector to generate pME18S- 
~100. pMElSS-plO0dX.S has a truncation at the 3’side of the X/z01 site 
in the cDNA, which generates additional Leu-Val and a stop codon 
following Arg”17 of ~100. cDNAs for chimera-A -B proteins were con- 
structed as follows. To generate chimera-A, the 1.37 kb EcoRI-RsaI 
fragment from pcDSRcc-~105, which corresponds to amino acids l-400 
of ~105, was inserted into the 4.45 kb XmuI-EcoRI fragment of 
pMEl8S-ply, which includes the cDNA corresponding to amino acids 
402-936 of ~100. For chimera-B, the 1.04 kb EcoRI-@III fragment 
from pME18SplO0, which corresponds to amino acids l-320 of plO0, 
was first inserted into the EcoRI-Smal site of pBluescript II SK’ vector 
(Stratagene) to generate PBS-~100 (l-320). Then, the EcoRI-S’eI frag- 
ment from PBS-~100 (l-320) was inserted into the SpeI-,??coRI site of 
pcDSRa-~105, which corresponds to amino acids 342-969 of p105, to 
generate pSRa-chimera-A. Therefore, the resulting chimer&B cDNA 
encodes polypeptides with amino acid l-320 of ~100, including the 
RHD, amino acid sequence -Gly-Gly-Ser- in the junction, and amino 
acids 342-969 of ~105 including the ARD. The DNA sequence of the 
j~ctional portion was confirmed by sequencing. 
All rights reserved. 
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2.3. Immunoblotting analysis, electrophoretic mobility shift assay 
(EMSA) and /@erase assay 
CO.57 cells were harvested 4248 h after transfection and nuclear and 
cytoplasmic fractions were prepared for immunoblotting or EMSA, as 
described elsewhere [7]. Luciferase assay was performed using Jurkat 
cells as hosts and a reporter gene, gm-95Luc with the 5’ promoter egion 
of the mouse GM-CSF gene and the luciferase structure gene [ 161. 
3. Results and discussion 
3.1. Expression of NFs32 ~100 cDNA in COS7 cells - w-0 -r, ~65 
NF-nB2 ~100 cDNA was transfected into COS7 cells, 
with or without Tax cDNA and the nuclear extract was 
subjected to EMSA. No significant NF-k-B binding activ- 
ity was observed, either in the presence or absence of Tax 
cDNA co-expression (Fig. 1A). Therefore, the response 
of ~100 and ~105 clearly differs, since co-expression of 
~105 and Tax markedly enhanced the binding activity in 
the COS7 cell nuclear extracts [7]. Transfection of 
Nuclear Cytoplasmic B 
A 
Nuclear Cytoplasmic B 
Jc 
.&- ,_ _‘35f -106 
- 80.0 
- 32.5 
Fig. 1. (A) NF-KB binding activity of the nuclear extracts from COS7 
cells transfected with cDNAs of pi00 or p1OOdxS. COS7 cells were 
transfected with 5 pg of pMEl8S-~100 or pMEl8S-pl~~XS, afone or 
in combination with 5 pg of pcDSRa-Tax, and EMSA was done as 
described in section 2. (B) Immunoblotting analysis of the nuclear and 
cytoplasmic fractions of COS7 cells transfected with pME18S-~100 (5 
pg) with or without pcDSRa-Tax (5 pg). 
Fig. 2. Shift of subcellular localization of NF-KB ~65. (A) COS7 cells 
were transfected with pMElSS-p65 (2 pg). pSRa-~105 (8 pg), or 
pcDSRa-Tax (2 pg) in combination, as described in the figure, and the 
nuclear and cytoplasmic fractions were subjected to immunoblotting 
analysis using an anti-p65 antibody. (B) COS7 cells were transfected 
with pME18Sp65 (2 lug), pMEl8S-ply (8 pg). or pcDSRa-Tax (2 fig) 
in combination and the nuclear and cytoplasmic fractions were sub- 
jected to immunoblotting analysis using an anti-p65 antibody, as de- 
scribed. (C) EMSA was performed with the nuclear extract used in (B) 
with an NF-nB probe. 
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plOOdXS cDNA generated a dense shift band, indicting 
that the RHD of ~100 retains binding activity. The level 
of NF-KB activity generated by plOOdXS was not af- 
fected by Tax co-expression (Fig. 1A). Immunoblotting 
analysis of nuclear and cytoplasmic extracts of COS7 
cells expressing ~100 cDNA showed that ~100 was pres- 
ent in both nuclear and cytoplasmic fractions (Fig. lB, 
upper arrow), but the processed form, which should ap- 
pear as a 52 kDa band, was not evident with im- 
munoblotting (Fig. lB, lower arrow). Co-expression of 
Tax cDNA slightly decreased the expression level of 
~100 but there was no evidence of a processed form (Fig. 
1B). Inefficient processing of ~100 is consistent with the 
observation in HeLa and Jurkat cells [17]. 
3.2. I#B function of NFxBlp105 and NF-k-B2 ~100 
expressed in COS7 cells 
Since 1~cB activity of ~100 towards its own processed 
form could not be tested due to inefficient processing, we 
examined the IFGB function towards NF-KB ~65. Expres- 
sion of p65 cDNA in COS7 cells generates ~65, which is 
distributed in both nuclear and cytoplasmic fractions 
(Fig. 2A and B). Co-expression of either ~105 or ~100 
cDNA reduced the amount of nuclear ~65 and increased 
the amount of cytoplasmic ~65 (Fig. 2A and B). This 
observation confirms that both ~10.5 and ~100 possess 
IlcB activity [7,13]. When Tax was further co-expressed, 
the level of nuclear ~65 was regained in cells expressing 
~65 and ~105 (Fig. 2A). In contrast, the level of nuclear 
~65 was not regained in cells expressing p65 and ~100 
(Fig. 2B). EMSA of the nuclear extracts used in Fig. 2B 
also shows that NF-KB binding activity is inhibited by 
~100 but is not enhanced by further Tax expression (Fig. 
2C). These results indicate that Tax inhibits IKB activity 
mediated by ~105 but not by ~100 in COS7 cells. 
3.3. Chimera between NF-KBI pIO5 and NF-lu;B2 pIO0 
cDNAs 
In an attempt to account for the different properties 
of ~105 and ~100, we constructed chimeric cDNAs by 
exchanging the amino-terminal region, including the 
RHD, and carboxy-terminal region, including the ARD 
(Fig. 3A). The chimera-A cDNA encodes the RHD of 
~105 and the ARD of ~100, while chimera-B cDNA 
encodes the RHD of ~100 and the ARD of ~105. Chi- 
mera-A and -B possess the nuclear localization signal 
(NLS) of NF-lcB1 and NF-xB2, respectively. 
When chimera-A cDNA was expressed in COS7 cells, 
a high level of 55 kDa protein was generated in the 
nuclear and cytoplasmic fractions (Fig. 3B, lower 
arrow), but a product corresponding to the size of the 
unprocessed protein was barely detectable (Fig. 3B, 
upper arrow). This suggests that chimera-A protein is so 
efficiently processed that the precursor is not retained in 
a detectable amount. In contrast, expression of chimera- 
B cDNA generated a 105 kDa product corresponding to 
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Fig. 3. (A) Structures of the chime& proteins between NF-KBI ~105 
and NF-rcB2 ~100. NLS, a putative nuclear localization signal; Gly 
rich, a polyglycine putative hinge domain; (FPXYG),, two copies of a 
sequence, FPXYG, which could serve as proteoIytic cleavage signal; 
RRKS, a putative protein kinase A phospho~lation site in ~105; 
KRKR, a sequence in ~100 which resides in the analogous position of 
RRKS in ~105. (B) Imm~obiotting analysis of COS7 cells expressing 
chimera-A cDNA with or without Tax cDNA. (C) Immunoblotting 
analysis of COS7 cells expressing chimera-B cDNA with or without Tax 
cDNA. 
the size of the intact chimera-B protein (Fig. 3C, upper 
arrow), but the processed form, which should appear as 
a 56-55 kDa band, was not detected (Fig. 3C, lower 
arrow). This indicates that chimera-B does not process 
efficiently. Co-expression of Tax cDNA with either chi- 
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Fig. 4. Effect of ~105, ~100 and other constructs on Tax- and p65- 
induced transactivation of the GM-CSF promoter. Jurkat cells were 
transfected with gm-95Luc, pMEl8Sp65 and pcDSRa-Tax in combi- 
nation with other constructs as shown in the figure. The luciferase 
activity of the extract from cells transfected with gm-95Luc and 
pMEl8S was arbitrarily assigned a value of 1 and the relative activities 
were calculated. 
mera-A or -B cDNA did not significantly affect the proc- 
essing or the subcellular localization of the chimera 
products (Fig. 3B and C). Since chimera-A and -B pos- 
sess the glycine-rich region and the FPXYG motifs of 
~105 which contain the putative processing site [18], 
these regions cannot be attributed to processing effi- 
ciency. Combining the results of chimera-A and -B, it is 
likely that the RHD but not ARD of ~100 has the inhib- 
itory effects on the processing in COS7 cells. 
3.4. NF-lcB2 ~100 inhibits Tax- and NF-KB p65-induced 
transactivation of a GM-CSFpromoter in Jurkat 
cells 
Next we examined the effect of ~100, ~105 and other 
constructs on Tax- and p65-induced transactivation of a 
GM-CSF promoter in Jurkat cells. The activity of the 
reporter gene, gm95-Luc, is at the basal level, and 
coexpression of Tax and ~65 cDNAs enhanced the pro- 
moter activity (Fig. 4, columns 1 and 2). Further co- 
expression of ~100 cDNA but not of ~105 cDNA inhib- 
ited promoter activity (Fig. 4, columns 5 and 3). Co- 
expression with either plOSdX, plOOdXS, chimera-A or 
-B cDNAs (Fig. 4, columns 4, 6, 7, 8, respectively) did 
not significantly suppress Tax- and p65-induced 
transactivation. It thus appears that ~100 inhibits Tax 
transactivation and that a proper structure of ~100 is 
required for efficient inhibition. 
In conclusion we obtained evidence that NF-lcB 1 ~105 
and NF-lcB2 ~100 show different responses to Tax. The 
interaction of Tax with ~105 may be one mechanism by 
which Tax induces NF-KB activity in the nucleus. Recent 
data shows that Tax binds to ankyrin motifs of InB and 
induces NF-KB proteins for transcriptional activation 
[19]. In contrast, the interaction of Tax with ~100 cannot 
be interpreted in such a straightforward manner. Al- 
though over-expression of ~100 has been shown to se- 
quester Tax in the cytoplasm [14], the physiological sig- 
nificance remains to be determined. It is conceivable that 
these different effects may affect Tax-induced 
transactivation events, and might render complexities in 
the pathophysiological role of Tax in HTLV-I infected 
cells. 
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